Supplementary table I- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Name: Supplementary table I- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al
Creator: Julia Vanlerberghe
Published: 2022-05-09T12:59:29.290Z
Keywords: Descriptive Table

Vanlerberghe, Julia

doi:10.17632/5zw326gw6v.1

Supplementary table I- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Published: 9 May 2022| Version 1 | DOI: 10.17632/5zw326gw6v.1

Contributor:

Julia Vanlerberghe

Description

Supplementary Table I : Characteristics of patients at baseline (before JAK inhibitor introduction)

Files

Institutions

Universite de Lille

Supplementary table I- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Description

Files

Institutions

Categories

License